Guided Therapeutics (GTHP) Return on Sales Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -89.00 |
| Sep 30, 2025 | -33.00 |
| Jun 30, 2025 | 173.00 |
| Mar 31, 2025 | -2,499.00 |
| Dec 31, 2024 | -720.00 |
| Sep 30, 2024 | 69.00 |
| Jun 30, 2024 | 2,606.00 |
| Mar 31, 2024 | -55.00 |
| Dec 31, 2023 | 53.00 |
| Sep 30, 2023 | 299.00 |
| Jun 30, 2023 | -463.00 |
| Mar 31, 2023 | -310.00 |
| Dec 31, 2022 | -252.00 |
| Sep 30, 2022 | -296.00 |
| Jun 30, 2022 | -173.00 |
| Mar 31, 2022 | -96.00 |
| Dec 31, 2021 | -12.00 |
| Sep 30, 2021 | 6.00 |
| Dec 31, 2020 | 282.00 |
| Sep 30, 2020 | 294.00 |
| Jun 30, 2020 | -10.00 |
| Mar 31, 2020 | 140.00 |
| Dec 31, 2019 | -1,207.00 |
| Sep 30, 2019 | 9.00 |
| Jun 30, 2019 | -2,467.00 |
| Mar 31, 2019 | -94.00 |
| Dec 31, 2018 | -72.00 |
| Sep 30, 2018 | -390.00 |
| Jun 30, 2018 | 420.00 |
| Mar 31, 2018 | 260.00 |
| Dec 31, 2017 | -83.00 |
| Sep 30, 2017 | -73.00 |
| Jun 30, 2017 | -11.00 |
| Mar 31, 2017 | -7.00 |
| Dec 31, 2016 | 1.00 |
| Sep 30, 2016 | -5.00 |
| Jun 30, 2015 | -170.00 |